IMMUNOME INC. (IMNM)
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
📈 **POSITIVE** • High confidence analysis (82%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business